Search research articles
Contact Us
Filters
Showing results (301-310 of 335) with videos related to
Page
of 34
Sort By:
Clinical and Experimental Dermatology
|
December 3, 2016
Treatment of severe, chronic hand eczema: results from a UK-wide survey
I L Smith, S Brown, J Nixon, et al.
The British Journal of Dermatology
|
July 10, 2019
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
S K Mahil, N Wilson, N Dand, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
March 4, 1999
Factors related to dropout in a study of head and neck cancer patients after surgery
L A Colangelo, J A Logemann, A W Rademaker, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
December 2, 1999
Relating speech and swallow function to dropout in a longitudinal study of head and neck cancer
L A Colangelo, J A Logemann, A W Rademaker, et al.
The British Journal of Dermatology
|
December 2, 2017
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)
M de Bruin-Weller, D Thaçi, C H Smith, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 12, 2006
Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial
J Berth-Jones, P D Arkwright, D Marasovic, et al.
The British Journal of Dermatology
|
April 8, 2021
Defining trajectories of response in patients with psoriasis treated with biologic therapies
N Geifman, N Azadbakht, J Zeng, et al.
The British Journal of Dermatology
|
January 11, 2019
Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review
K J Mason, S Williams, Z Z N Yiu, et al.
The British Journal of Dermatology
|
May 20, 2015
Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register
I Y K Iskandar, D M Ashcroft, R B Warren, et al.
Trials
|
May 29, 2020
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial
C M Sackley, C Rick, P Au, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 335) with videos related to
Sort By:
Page
of 34
Clinical and Experimental Dermatology
|
December 3, 2016
Treatment of severe, chronic hand eczema: results from a UK-wide survey
I L Smith, S Brown, J Nixon, et al.
The British Journal of Dermatology
|
July 10, 2019
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
S K Mahil, N Wilson, N Dand, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
March 4, 1999
Factors related to dropout in a study of head and neck cancer patients after surgery
L A Colangelo, J A Logemann, A W Rademaker, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
December 2, 1999
Relating speech and swallow function to dropout in a longitudinal study of head and neck cancer
L A Colangelo, J A Logemann, A W Rademaker, et al.
The British Journal of Dermatology
|
December 2, 2017
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)
M de Bruin-Weller, D Thaçi, C H Smith, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 12, 2006
Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial
J Berth-Jones, P D Arkwright, D Marasovic, et al.
The British Journal of Dermatology
|
April 8, 2021
Defining trajectories of response in patients with psoriasis treated with biologic therapies
N Geifman, N Azadbakht, J Zeng, et al.
The British Journal of Dermatology
|
January 11, 2019
Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review
K J Mason, S Williams, Z Z N Yiu, et al.
The British Journal of Dermatology
|
May 20, 2015
Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register
I Y K Iskandar, D M Ashcroft, R B Warren, et al.
Trials
|
May 29, 2020
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial
C M Sackley, C Rick, P Au, et al.
Page
of 34